Spire Wealth Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Spire Wealth Management’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-200	Closed	-$8K	–	3116
2021 Q1	$8K	Buy	+200	New	+$4.99K	﹤0.01%	2506

Spire Wealth Management's FPRX Position: Q2 2021 in Review

Spire Wealth Management sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 200 shares — an estimated $8K sold.

Spire Wealth Management first reported a position in FPRX in Q1 2021 and held it in 1 quarter. The position peaked at $8K in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

Spire Wealth Management reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
Spire Wealth Management sold 200 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $8K.
Spire Wealth Management first reported a position in Five Prime Therapeutics, Inc. in Q1 2021 and held it in 1 quarter.
Spire Wealth Management's Five Prime Therapeutics, Inc. position peaked at $8K in Q1 2021.
0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Spire Wealth Management's 13F filing for Q2 2021, filed 26 Jul 2021.